Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
141.2 USD | -3.12% | -6.07% | -21.45% |
Chart calendar Repligen Corporation
Upcoming events on Repligen Corporation
Past events on Repligen Corporation
2024-06-06 11:30 am | Jefferies Global Healthcare Conference |
2024-06-05 01:00 pm | William Blair Growth Stock Conference |
2024-05-30 09:40 am | Leerink Partners Healthcare Crossroads Conference |
2024-05-28 | Craig Hallum Institutional Investor Conference |
2024-05-20 | Benchmark Healthcare House Virtual Conference |
2024-05-16 08:00 am | Annual General Meeting |
2024-05-14 10:30 am | RBC Capital Markets Global Healthcare Conference |
2024-05-01 08:30 am | Q1 2024 Earnings Call |
2024-04-30 | Q1 2024 Earnings Release Pre-market |
2024-03-19 | KeyBanc Life Sciences & MedTech Forum |
2024-02-21 08:30 am | Q4 2023 Earnings Call |
2024-02-21 07:30 am | Q4 2023 Earnings Release |
2024-01-09 05:15 pm | JPMorgan Healthcare Conference |
2023-11-16 11:00 am | Stephens Investment Conference |
2023-11-15 08:00 am | Stifel Healthcare Conference |
2023-10-31 08:30 am | Q3 2023 Earnings Call |
2023-10-31 07:30 am | Q3 2023 Earnings Release |
2023-09-08 10:15 am | Wells Fargo Healthcare Conference |
2023-08-02 08:30 am | Q2 2023 Earnings Call |
2023-08-02 07:30 am | Q2 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 270 269 0.41% | 366 352 4.19% | 671 662 1.24% | 802 800 0.24% | 639 638 0.08% | 638 |
EBITDA Million USD | Released Forecast Spread | 71,1 70,6 0.73% | 108 103 4.57% | 231 223 3.2% | 247 251 -1.56% | 128 133 -3.79% | 111 |
EBIT Million USD | Released Forecast Spread | 63,5 63,3 0.42% | 98,1 93,0 5.48% | 215 208 3.63% | 232 235 -1.23% | 94,3 96,7 -2.47% | 83,9 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 26,2 24,2 8.25% | 59,2 56,7 4.44% | 154 155 -1.07% | 219 197 11.05% | 64,1 81,3 -21.09% | 38,8 |
Net income Million USD | Released Forecast Spread | 21,4 20,2 5.99% | 59,9 49,6 20.81% | 128 128 0.09% | 186 161 15.5% | 41,6 73,6 -43.54% | 45,8 |
EPS USD | Released Forecast Spread | 0,44 0,46 -4.69% | 1,11 0,93 19.35% | 2,24 2,24 -0.09% | 3,24 2,80 15.92% | 0,74 1,30 -42.86% | 0,58 |
Announcement Date | 20/02/20 | 24/02/21 | 17/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 206 185 11.28% | 208 189 9.82% | 201 191 4.83% | 187 184 1.28% | 183 181 0.68% | 159 166 -4.07% | 141 141 0.39% | 156 156 -0.36% | 151 150 0.85% | 154 | 161 | 170 | 173 | 181 |
EBITDA Million USD | Released Forecast Spread | 72,2 59,8 20.82% | 67,7 60,3 12.2% | 57,9 58,1 -0.26% | 49,1 50,6 -3.13% | 48,9 48,5 0.8% | 38,4 39,4 -2.43% | 14,5 18,3 -20.98% | 26,2 29,6 -11.37% | 20,2 24,3 -16.76% | 25,8 | 30,2 | 35,1 | 35,2 | 39,6 |
EBIT Million USD | Released Forecast Spread | 67,4 53,3 26.49% | 65,6 53,3 23.03% | 58,2 51,9 11.99% | 41,1 44,1 -6.73% | 40,9 39,9 2.31% | 29,4 30,5 -3.51% | 5,17 8,57 -39.72% | 18,8 21,3 -11.47% | 11,8 16,5 -28.45% | 19,0 | 23,7 | 29,1 | 27,8 | 32,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 58,9 38,0 55.02% | 59,8 42,1 41.84% | 47,5 36,1 31.66% | 53,0 32,3 63.98% | 36,1 30,0 20.47% | 25,2 22,0 14.53% | 11,6 0,66 1658.73% | -8,76 8,53 -202.65% | 2,11 5,64 -62.54% | 6,18 | 12,0 | 18,6 | 19,9 | 22,6 |
Net income Million USD | Released Forecast Spread | 47,0 30,5 53.87% | 49,9 32,6 53.03% | 40,4 29,0 39.41% | 48,7 23,8 105.03% | 28,8 26,0 10.82% | 20,1 18,0 11.28% | 18,2 0,28 6309.88% | -25,5 8,74 -391.67% | 2,09 6,54 -67.97% | 7,96 | 12,5 | 16,1 | 17,2 | 21,7 |
EPS USD | Released Forecast Spread | 0,81 0,53 53.55% | 0,88 0,56 55.85% | 0,71 0,51 39.25% | 0,85 0,41 105.13% | 0,51 0,46 11.96% | 0,35 0,32 10.92% | 0,32 0,00 8255.09% | -0,46 0,15 -399.75% | 0,04 0,08 -46.67% | 0,10 | 0,19 | 0,26 | 0,28 | 0,32 |
Announcement Date | 27/04/22 | 02/08/22 | 01/11/22 | 22/02/23 | 02/05/23 | 02/08/23 | 31/10/23 | 21/02/24 | 01/05/24 | - | - | - | - | - |
2024-06-18 | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release (Projected) |
2024-06-26 | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
2024-07-04 | MANI, INC.: Q3 2024 Earnings Release |
2024-07-11 01:00 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
2024-07-11 | ARJO AB: Q2 2024 Earnings Release |
2024-07-12 01:30 am | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
2024-07-17 | ABBOTT LABORATORIES: Q2 2024 Earnings Release (Projected) |
2024-07-17 | MEDMIX AG: Q2 2024 Earnings Release |
2024-07-19 01:00 am | SARTORIUS STEDIM BIOTECH: Q2 2024 Earnings Release |
2024-07-22 | NEOGEN CORPORATION: Q4 2024 Earnings Release (Projected) |
Past sector events for Repligen Corporation
2024-06-05 06:00 am | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
2024-05-27 04:30 pm | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
2024-05-23 06:45 am | MEDTRONIC PLC: Q4 2024 Earnings Release |
2024-05-22 01:00 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
2024-05-17 04:19 am | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
2024-05-16 02:00 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
2024-05-14 10:00 pm | HOYA CORPORATION: Q4 2023 Earnings Release |
2024-05-14 01:00 am | AMBU A/S: Q2 2024 Earnings Release |
2024-05-13 | HLB CO., LTD.: Q1 2024 Earnings Release |
2024-05-13 | TERUMO CORPORATION: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RGEN Stock
- Calendar Repligen Corporation